Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$55.24 0.49 (0.88%) as of 4:30 Fri 5/24


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 3.90(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 61,438 159,721 184,721 409,721
Total Sell Value $4,291,798 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 7 12 13 22
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 483
  Page 17 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-20 4 AS $15.00 $48,785 D/D (3,252) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-20 4 OE $1.81 $5,886 D/D 3,252 1,218,257     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-19 4 AS $15.00 $230,880 D/D (15,392) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-19 4 OE $1.81 $27,860 D/D 15,392 1,230,397     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-09 4 AS $15.08 $16,583 D/D (1,100) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-09 4 OE $1.81 $1,991 D/D 1,100 1,216,105     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-08 4 AS $15.00 $63,045 D/D (4,203) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-06-08 4 OE $1.81 $7,607 D/D 4,203 1,219,208     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-30 4 AS $15.02 $54,829 D/D (3,650) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-30 4 OE $1.81 $6,607 D/D 3,650 1,218,655     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-17 4 AS $16.03 $415,577 D/D (25,923) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-17 4 OE $1.81 $46,921 D/D 25,923 1,240,928     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-16 4 AS $16.50 $397,283 D/D (24,077) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-16 4 OE $1.81 $43,579 D/D 24,077 1,239,082     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-05 4 AS $16.92 $10,426 D/D (616) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-05 4 OE $1.81 $1,115 D/D 616 1,215,621     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-04 4 AS $16.37 $215,960 D/D (13,191) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-04 4 OE $1.81 $23,876 D/D 13,191 1,229,196     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-03 4 AS $16.05 $325,986 D/D (20,269) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-03 4 OE $1.81 $36,687 D/D 20,269 1,235,274     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-02 4 AS $16.53 $263,236 D/D (15,924) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-05-02 4 OE $1.81 $28,822 D/D 15,924 1,230,929     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-05-01 4 AS $16.61 $30,753 D/D (1,852) 168,204     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-28 4 AS $16.62 $81,638 D/D (4,912) 170,056     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-27 4 AS $16.84 $227,799 D/D (13,527) 174,968     -
  483 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us